At the 33rd WT – Wearables Technologies Conference – in Munich, the world’s most profound and comprehensive wearable technologies event, Coala´s CEO Philip Siberg presented data and outcomes “Connecting and saving hearts, based on the power of the individual. Simply digital perfection – sticky and patch free.”
Aleris and Coala Life in collaboration to digitize cardiac care
STOCKHOLM, November 22, 2019 – Implementation of the Coala Heart Monitor leads to higher clinical efficiency, lower costs, shorter waiting lists and higher patient satisfaction. That is the results of a clinical evaluation performed at the Cardiology Clinic at Aleris Sabbatsberg. In 2019, Aleris Cardiology Clinic at Sabbatsberg hospital used Coala Heart Monitor to …
First US patient diagnosed and treated for AF thanks to the Coala
St. Louis Cardiology Center clinic was first in the U.S. to use the Coala Heart Monitor for the remote monitoring of patients with suspected AF. Jerome Dwyer M.D. M.B.A. commented; “The real-time Coala monitor reduces patient cost, contributes to lowering U.S. healthcare spending, while at the same time improving diagnostic accuracy for my patients. Plus …
The St. Louis Business Journal highlights Coala on its US expansion
“Swedish medical device startup expands into St. Louis A Swedish medical device startup has expanded into St. Louis, with the possibility that it could locate its U.S. headquarters here.” Read full article here.
Introducing the Coala Life US Advisory Board
Coala Life is proud to announce the formation of the new US clinical advisory board. First meeting held at the new BioSTL headquarters in St Louis. Jerome V. Dwyer, MD, MBA, Cardiologist and Electrophysiologist, St. Louis Cardiology Center. Dr. Dwyer is a serial entrepreneur, investor, fundraiser, advisor, and physician whose passion is creating and growing …
Coala Life launches in the US
Irvine, CA, US – October 2nd, 2019 – Swedish digital health company Coala Life today announced its market launch in the US in collaboration with leading US cardiologists and healthcare providers. The launch follows recent FDA clearance for the Coala Heart Monitor and subsequent A-series funding. The Coala Heart Monitor (“Coala”) is a real-time …
Coala Life partners with Luscii to enter the Dutch market
STOCKHOLM August 30, 2019 – Today Coala Life announces entry into the Dutch market in partnership with Luscii. The Netherlands, with healthcare expenditures approaching $100 Bn, is a major and influential hub in the European medical device industry frequently ranked in the top 5 global medical device markets. The Swedish medtech company Coala Life, …